Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023Business Wire • 05/17/23
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?Zacks Investment Research • 05/08/23
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingBusiness Wire • 05/04/23
HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their OptionsPRNewsWire • 04/22/23
HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their OptionsPRNewsWire • 04/01/23
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWMPRNewsWire • 03/30/23